Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02068144 · ClinicalTrials.gov registry record · NA
The Effect of Cranberry Extract Supplementation on Cardiovascular Risk Factors in Obese, Insulin Resistant Humans
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT02068144 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 35 participants.
The verdict
NCT02068144, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the health benefits of cranberry extract in people who are at risk for diabetes and heart problems.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Cranberry Extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2014-02 |
| Est. Completion | 2018-07-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02068144
The ClinicalTrials.gov registry entry for NCT02068144 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02068144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02068144 about?
NCT02068144 is a clinical study titled "The Effect of Cranberry Extract Supplementation on Cardiovascular Risk Factors in Obese, Insulin Resistant Humans". The purpose of this study is to determine the health benefits of cranberry extract in people who are at risk for diabetes and heart problems.
What is the current status of trial NCT02068144?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2014-02. Estimated completion is 2018-07-11.
What interventions are being tested in trial NCT02068144?
The interventions under investigation include: Placebo (OTHER), Cranberry Extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02068144?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.